Xenon Pharmaceuticals
XENE
XENE
174 hedge funds and large institutions have $2.36B invested in Xenon Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 56
0.52% less ownership
Funds ownership: 97% → 96.48% (-0.52%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
174
Holding in Top 10
7
Calls
$5.17M
Puts
$3.07M
Top Buyers
| 1 | +$30.9M | |
| 2 | +$26.3M | |
| 3 | +$21.1M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$18.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.7M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$23.4M | |
| 3 | -$14.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$13.1M |